Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TQ-F3083 capsules in type 2 diabetes mellitus
CTR20191143Phase 2Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TQ-F3083 in type 2 diabetes mellitus (T2DM), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Jun 2019; status: completed.
02
Drugs
TQ-F3083
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20191143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20191143.